{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T09:40:05Z","timestamp":1751190005847,"version":"3.41.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,29]]},"DOI":"10.7759\/cureus.86945","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T08:59:51Z","timestamp":1751187591000},"source":"Crossref","is-referenced-by-count":0,"title":["A Systematic Review: Efficacy of Different Intraocular Pressure-Lowering Agents in Black Individuals"],"prefix":"10.7759","author":[{"given":"Risantini","family":"Murugan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veylamuthen","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj K","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Kanski's Clinical Ophthalmology: A Systematic Approach","author":"Bowling B","year":"2016","unstructured":"Bowling B, Kanski JJ. Kanski's Clinical Ophthalmology: A Systematic Approach. Elsevier, Edinburgh; 2016."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2016.02.003","article-title":"Glaucoma history and risk factors","volume":"10","author":"McMonnies CW","year":"2017","unstructured":"McMonnies CW. Glaucoma history and risk factors. J Optom. 2017, 10:71-8. 10.1016\/j.optom.2016.02.003","journal-title":"J Optom"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0633-6","article-title":"Treatment choices for newly diagnosed primary open angle and ocular hypertension patients","volume":"34","author":"Garg A","year":"2019","unstructured":"Garg A, Gazzard G. Treatment choices for newly diagnosed primary open angle and ocular hypertension patients. Eye (Lond). 2019, 34:60-71. 10.1038\/s41433-019-0633-6","journal-title":"Eye (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.110605","article-title":"Epidemiology of glaucoma in Sub\u2011Saharan Africa: prevalence, incidence and risk factors","volume":"20","author":"Kyari F","year":"2013","unstructured":"Kyari F, Abdull MM, Bastawrous A, Gilbert CE, Faal H. Epidemiology of glaucoma in Sub\u2011Saharan Africa: prevalence, incidence and risk factors. Middle East Afr J Ophthalmol. 2013, 20:111-25. 10.4103\/0974-9233.110605","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref5","article-title":"Myocilin mutations in black South Africans with POAG","volume":"17","author":"Whigham BT","year":"2011","unstructured":"Whigham BT, Williams SE, Liu Y, et al.. Myocilin mutations in black South Africans with POAG. Mol Vis. 2011, 17:1064-9.","journal-title":"Mol Vis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-018-0392-4","article-title":"Local genetic ancestry in CDKN2B-AS1 is associated with primary open-angle glaucoma in an African American cohort extracted from de-identified electronic health records","volume":"11","author":"Restrepo NA","year":"2018","unstructured":"Restrepo NA, Laper SM, Farber-Eger E, Crawford DC. Local genetic ancestry in CDKN2B-AS1 is associated with primary open-angle glaucoma in an African American cohort extracted from de-identified electronic health records. BMC Med Genomics. 2018, 11:70. 10.1186\/s12920-018-0392-4","journal-title":"BMC Med Genomics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.01.032","article-title":"Corneal hysteresis as a risk factor for glaucoma progression: a prospective longitudinal study","volume":"120","author":"Medeiros FA","year":"2013","unstructured":"Medeiros FA, Meira-Freitas D, Lisboa R, Kuang TM, Zangwill LM, Weinreb RN. Corneal hysteresis as a risk factor for glaucoma progression: a prospective longitudinal study. Ophthalmology. 2013, 120:1533-40. 10.1016\/j.ophtha.2013.01.032","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000130","article-title":"Corneal hysteresis and its relevance to glaucoma","volume":"26","author":"Deol M","year":"2015","unstructured":"Deol M, Taylor DA, Radcliffe NM. Corneal hysteresis and its relevance to glaucoma. Curr Opin Ophthalmol. 2015, 26:96-102. 10.1097\/ICU.0000000000000130","journal-title":"Curr Opin Ophthalmol"},{"key":"ref9","unstructured":"Scenario. primary open angle glaucoma and ocular hypertension. (2023). Accessed: 26 June 2025: https:\/\/cks.nice.org.uk\/topics\/glaucoma\/management\/primary-open-angle-glaucoma-intraocular-hypertension\/."},{"key":"ref10","unstructured":"PRISMA 2020 checklist. (2020). Accessed. 26 June 2025: https:\/\/www.prisma-statement.org\/prisma-2020-checklist."},{"key":"ref11","unstructured":"PROSPERO. (2019). Accessed. 26 June 2025: https:\/\/www.crd.york.ac.uk\/PROSPERO\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness LA","year":"2021","unstructured":"McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021, 12:55-61. 10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.4.454","article-title":"Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study","volume":"125","author":"Mansberger SL","year":"2007","unstructured":"Mansberger SL, Hughes BA, Gordon MO, Spaner SD, Beiser JA, Cioffi GA, Kass MA. Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2007, 125:454-9. 10.1001\/archopht.125.4.454","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X148418","article-title":"Comparing bimatoprost and travoprost in black Americans","volume":"22","author":"Noecker RJ","year":"2006","unstructured":"Noecker RJ, Earl ML, Mundorf TK, Silverstein SM, Phillips MP. Comparing bimatoprost and travoprost in black Americans. Curr Med Res Opin. 2006, 22:2175-80. 10.1185\/030079906X148418","journal-title":"Curr Med Res Opin"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850153","article-title":"Efficacy of latanoprost and timolol maleate in black and white patients","volume":"21","author":"Kitnarong N","year":"2004","unstructured":"Kitnarong N, Zhao Y, Netland PA, Kent AR. Efficacy of latanoprost and timolol maleate in black and white patients. Adv Ther. 2004, 21:203-13. 10.1007\/BF02850153","journal-title":"Adv Ther"},{"key":"ref17","unstructured":"Glaucoma. diagnosis and management. (2022). Accessed: 26 June 2025: https:\/\/www.nice.org.uk\/guidance\/ng81."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/15569527.2024.2402408","article-title":"A national analysis of systemic adverse events of beta-blockers used for glaucoma therapy","volume":"43","author":"Aftab OM","year":"2024","unstructured":"Aftab OM, Khan H, Sangani R, Khouri AS. A national analysis of systemic adverse events of beta-blockers used for glaucoma therapy. Cutan Ocul Toxicol. 2024, 43:293-8. 10.1080\/15569527.2024.2402408","journal-title":"Cutan Ocul Toxicol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201810-1909PP","article-title":"Chronic obstructive pulmonary disease in America\u2019s Black population","volume":"200","author":"Ejike CO","year":"2019","unstructured":"Ejike CO, Dransfield MT, Hansel NN, Putcha N, Raju S, Martinez CH, Han MK. Chronic obstructive pulmonary disease in America\u2019s Black population. Am J Respir Crit Care Med. 2019, 200:423-30. 10.1164\/rccm.201810-1909PP","journal-title":"Am J Respir Crit Care Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00562.x","article-title":"Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel","volume":"83","author":"Uusitalo H","year":"2005","unstructured":"Uusitalo H, Ni\u00f1o J, Tahvanainen K, Turjanmaa V, Ropo A, Tuominen J, K\u00e4h\u00f6nen M. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel. Acta Ophthalmol Scand. 2005, 83:723-8. 10.1111\/j.1600-0420.2005.00562.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3310\/hta23310","article-title":"Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT","volume":"23","author":"Gazzard G","year":"2019","unstructured":"Gazzard G, Konstantakopoulou E, Garway-Heath D, et al.. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT. Health Technol Assess. 2019, 23:1-102. 10.3310\/hta23310","journal-title":"Health Technol Assess"},{"key":"ref22","article-title":"Central corneal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations","volume":"119","author":"La Rosa FA","year":"2001","unstructured":"La Rosa FA, Gross RL, Orengo-Nania S. Central corneal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations. Arch Ophthalmol. 2001, 119:23-7.","journal-title":"Arch Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1994.64","article-title":"The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London","volume":"8 ( Pt 3)","author":"Wormald RP","year":"1994","unstructured":"Wormald RP, Basauri E, Wright LA, Evans JR. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London. Eye (Lond). 1994, 8 ( Pt 3):315-20. 10.1038\/eye.1994.64","journal-title":"Eye (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381725-a-systematic-review-efficacy-of-different-intraocular-pressure-lowering-agents-in-black-individuals","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T08:59:53Z","timestamp":1751187593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381725-a-systematic-review-efficacy-of-different-intraocular-pressure-lowering-agents-in-black-individuals"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,29]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.86945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,6,29]]}}}